Literature DB >> 25569261

The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice.

S Tokuda1, T Z Do Valle2, L Batista3, D Simon-Chazottes1, L Guillemot1, M Bouloy4, M Flamand5, X Montagutelli1, J-J Panthier1.   

Abstract

The large variation in individual response to infection with Rift Valley fever virus (RVFV) suggests that host genetic determinants play a role in determining virus-induced disease outcomes. These genetic factors are still unknown. The systemic inoculation of mice with RVFV reproduces major pathological features of severe human disease, notably the hepatitis and encephalitis. A genome scan performed on 546 (BALB/c × MBT) F2 progeny identified three quantitative trait loci (QTLs), denoted Rvfs-1 to Rvfs-3, that were associated with disease susceptibility in MBT/Pas mice. Non-parametric interval-mapping revealed one significant and two suggestive linkages with survival time on chromosomes 2 (Rvfs-1), 5 (Rvfs-3) and 11 (Rvfs-2) with respective logarithm of odds (LOD) scores of 4.58, 2.95 and 2.99. The two-part model, combining survival time and survival/death, identified one significant linkage to Rvfs-2 and one suggestive linkage to Rvfs-1 with respective LOD scores of 5.12 and 4.55. Under a multiple model, with additive effects and sex as a covariate, the three QTLs explained 8.3% of the phenotypic variance. Sex had the strongest influence on susceptibility. The contribution of Rvfs-1, Rvfs-2 and Rvfs-3 to survival time of RVFV-infected mice was further confirmed in congenic mice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25569261     DOI: 10.1038/gene.2014.79

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  45 in total

Review 1.  Animal models of Rift Valley fever virus infection.

Authors:  Ted M Ross; Nitin Bhardwaj; Stephanie J Bissel; Amy L Hartman; Darci R Smith
Journal:  Virus Res       Date:  2011-11-04       Impact factor: 3.303

2.  Genome-wide genetic association of complex traits in heterogeneous stock mice.

Authors:  William Valdar; Leah C Solberg; Dominique Gauguier; Stephanie Burnett; Paul Klenerman; William O Cookson; Martin S Taylor; J Nicholas P Rawlins; Richard Mott; Jonathan Flint
Journal:  Nat Genet       Date:  2006-07-09       Impact factor: 38.330

3.  Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs.

Authors:  M Bouloy; C Janzen; P Vialat; H Khun; J Pavlovic; M Huerre; O Haller
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 4.  Controlling complexity: the clinical relevance of mouse complex genetics.

Authors:  Klaus Schughart; Claude Libert; Martien J Kas
Journal:  Eur J Hum Genet       Date:  2013-05-01       Impact factor: 4.246

5.  Infection of inbred rat strains with Rift Valley fever virus: development of a congenic resistant strain and observations on age-dependence of resistance.

Authors:  G W Anderson; J A Rosebrock; A J Johnson; G B Jennings; C J Peters
Journal:  Am J Trop Med Hyg       Date:  1991-05       Impact factor: 2.345

Review 6.  Molecular biology and genetic diversity of Rift Valley fever virus.

Authors:  Tetsuro Ikegami
Journal:  Antiviral Res       Date:  2012-06-16       Impact factor: 5.970

7.  The pathogenesis of Rift Valley fever virus in the mouse model.

Authors:  Darci R Smith; Keith E Steele; Joshua Shamblin; Anna Honko; Joshua Johnson; Christopher Reed; Maureen Kennedy; Jennifer L Chapman; Lisa E Hensley
Journal:  Virology       Date:  2010-09-17       Impact factor: 3.616

8.  Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates.

Authors:  Nuria Busquets; F Xavier; Raquel Martín-Folgar; Gema Lorenzo; Iván Galindo-Cardiel; Bernat Pérez del Val; Raquel Rivas; Javier Iglesias; Fernando Rodríguez; David Solanes; Mariano Domingo; Alejandro Brun
Journal:  Vector Borne Zoonotic Dis       Date:  2010-10       Impact factor: 2.133

9.  Rift Valley Fever among febrile patients at New Halfa hospital, eastern Sudan.

Authors:  Ahmed M Hassanain; Waleed Noureldien; Mubarak S Karsany; El Najeeb S Saeed; Imadeldin E Aradaib; Ishag Adam
Journal:  Virol J       Date:  2010-05-13       Impact factor: 4.099

10.  Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.

Authors:  Céline Gommet; Agnès Billecocq; Grégory Jouvion; Milena Hasan; Tânia Zaverucha do Valle; Laurent Guillemot; Charlène Blanchet; Nico van Rooijen; Xavier Montagutelli; Michèle Bouloy; Jean-Jacques Panthier
Journal:  PLoS Negl Trop Dis       Date:  2011-12-06
View more
  6 in total

1.  Genetic Diversity of Collaborative Cross Mice Controls Viral Replication, Clinical Severity, and Brain Pathology Induced by Zika Virus Infection, Independently of Oas1b.

Authors:  Caroline Manet; Etienne Simon-Lorière; Grégory Jouvion; David Hardy; Matthieu Prot; Laurine Conquet; Marie Flamand; Jean-Jacques Panthier; Anavaj Sakuntabhai; Xavier Montagutelli
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

2.  Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model.

Authors:  Haley N Cartwright; Dominique J Barbeau; Joshua D Doyle; Ed Klein; Mark T Heise; Martin T Ferris; Anita K McElroy
Journal:  PLoS Pathog       Date:  2022-07-14       Impact factor: 7.464

3.  Identification of Single Amino Acid Changes in the Rift Valley Fever Virus Polymerase Core Domain Contributing to Virus Attenuation In Vivo.

Authors:  Belén Borrego; Sandra Moreno; Álvaro López-Valiñas; Nuria de la Losa; Friedemann Weber; José Ignacio Núñez; Alejandro Brun
Journal:  Front Cell Infect Microbiol       Date:  2022-04-28       Impact factor: 6.073

4.  Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.

Authors:  Elizabeth R Wonderlich; Amy L Caroline; Cynthia M McMillen; Aaron W Walters; Douglas S Reed; Simon M Barratt-Boyes; Amy L Hartman
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

5.  NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice.

Authors:  Psylvia Léger; Eliana Nachman; Karsten Richter; Carole Tamietti; Jana Koch; Robin Burk; Susann Kummer; Qilin Xin; Megan Stanifer; Michèle Bouloy; Steeve Boulant; Hans-Georg Kräusslich; Xavier Montagutelli; Marie Flamand; Carmen Nussbaum-Krammer; Pierre-Yves Lozach
Journal:  Nat Commun       Date:  2020-07-01       Impact factor: 14.919

6.  Innate Immune Basis for Rift Valley Fever Susceptibility in Mouse Models.

Authors:  Rashida Lathan; Dominique Simon-Chazottes; Grégory Jouvion; Ophélie Godon; Marie Malissen; Marie Flamand; Pierre Bruhns; Jean-Jacques Panthier
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.